Novel aminopyridine derivatives having Aurora A selective inhibitory action

Details for Australian Patent Application No. 2010229141 (hide)

Owner Vertex Pharmaceuticals Incorporated MSD K.K.

Inventors Iwama, Toshiharu; Kawanishi, Nobuhiko; Mortimore, Michael; Ohkubo, Mitsuru; Sunami, Tomoko

Agent Spruson & Ferguson

Pub. Number AU-A-2010229141

PCT Pub. Number WO2010/111057

Priority 61/162,711 24.03.09 US

Filing date 15 March 2010

Wipo publication date 30 September 2010

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Event Publications

10 November 2011 PCT application entered the National Phase

  PCT publication WO2010/111057 Priority application(s): WO2010/111057

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010229142-P2X3, receptor antagonists for treatment of pain

2010229140-Novel aminopyridine derivatives having Aurora A selective inhibitory action